| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | Phase II | rekrutiert |
| A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | Phase I | rekrutiert |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients | Phase III | rekrutiert |
| A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Saf | Phase I / Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and You | Phase II | rekrutiert |
| A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Co | Phase II / Phase III | rekrutiert |
| A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in | — | rekrutiert |
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic | Phase II | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanc | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disea | Phase III | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multi | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosi | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents W | Phase II / Phase III | rekrutiert |
| A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastat | Phase III | rekrutiert |
| A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in P | Phase III | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel | Phase I / Phase II | rekrutiert |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving | Phase I | rekrutiert |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chro | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experience | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cir | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients U | ohne Phasenangabe | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injec | Phase III | rekrutiert |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients Wit | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prosta | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Phase III | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Sei | Phase III | rekrutiert |
| AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT | — | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA | Phase II / Phase III | rekrutiert |
| An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in | Phase III | rekrutiert |
| An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Stud | Phase III | rekrutiert |
| Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transp | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreat | Phase II | rekrutiert |
| Brain Signal Training to Enhance Affect Down-regulation | Phase I / Phase II | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery | — | rekrutiert |
| Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems | — | rekrutiert |
| Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma | ohne Phasenangabe | rekrutiert |
| Clinical Study on the Safety and Efficacy of the Minimally Invasive Ennovate® Method for Pedicle | ohne Phasenangabe | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combination of Hypothermia and Thrombectomy in Acute Stroke | Phase III | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Disease | ohne Phasenangabe | rekrutiert |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig P | Phase III | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Tr | ohne Phasenangabe | rekrutiert |
| EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpe | Phase II | rekrutiert |
| Early Detection and IntervenTion in Heart Failure | ohne Phasenangabe | rekrutiert |
| Early TIPS in Patients With Liver Cirrhosis and Ascites | ohne Phasenangabe | rekrutiert |
| Effects of Oncological Treatment During Pregnancy on Mother and Child | — | rekrutiert |
| Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis | Phase II | rekrutiert |
| Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care | Phase III | rekrutiert |
| Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia ( | Phase III | rekrutiert |
| Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HF | Phase II | rekrutiert |
| Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therap | Phase III | rekrutiert |
| Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopul | Phase II / Phase III | rekrutiert |
| Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular | Phase III | rekrutiert |
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failur | Phase II / Phase III | rekrutiert |
| Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer | — | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| Establishment of a Tumor Bank for Blood Samples | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | Phase III | rekrutiert |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Phase III | rekrutiert |
| Freiburg TIPS Registry | — | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project | ohne Phasenangabe | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| HRS-AKI Treatment With TIPS in Patients With Cirrhosis | ohne Phasenangabe | rekrutiert |
| Hearing and Structure Preservation Via ECochG | ohne Phasenangabe | rekrutiert |
| High Dose Steroids in Children With Stroke | Phase III | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Ster | ohne Phasenangabe | rekrutiert |
| Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC | Phase II | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Investigation of a New Window Into Intracranial Pressure: Venous Occlusion Pressure of the Isola | ohne Phasenangabe | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| Lebrikizumab in Moderate-to-severe Atopic Dermatitis | Phase IV | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical | — | rekrutiert |
| Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Compl | Phase III | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multi | Phase III | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL | Phase II | rekrutiert |
| Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT | Phase III | rekrutiert |
| Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-orient | ohne Phasenangabe | rekrutiert |
| Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE | — | rekrutiert |
| Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections | Phase III | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| OP2C : Prialt® Observatory in Clinical Practice | — | rekrutiert |
| One-Month DAPT in CABG Patients | Phase III | rekrutiert |
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced N | Phase II | rekrutiert |
| PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Pathogen-microbiome Interaction During Helicobacter Pylori Infection | — | rekrutiert |
| Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) | Phase I / Phase II | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally A | Phase III | rekrutiert |
| Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Ca | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid T | Phase I / Phase II | rekrutiert |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combinat | Phase III | rekrutiert |
| Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive | Phase III | rekrutiert |
| Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanc | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Pompe Disease Registry Protocol | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2 | ohne Phasenangabe | rekrutiert |
| Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [Cross | ohne Phasenangabe | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Pro | — | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma | Phase II | rekrutiert |
| Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer | Phase III | rekrutiert |
| REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization | — | rekrutiert |
| ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast C | Phase III | rekrutiert |
| Radial Versus Femoral Secondary Access in Patients Undergoing TAVI | ohne Phasenangabe | rekrutiert |
| Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neopl | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry for Patients With X-Linked Hypophosphatemia | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With T | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment | — | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | Phase III | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With | Phase II | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Spinal CSF Leaks in Chronic Subdural Hematoma | — | rekrutiert |
| Staphylococcus Aureus Network Adaptive Platform Trial | Phase IV | rekrutiert |
| Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available The | Phase III | rekrutiert |
| Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myel | — | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced C | Phase III | rekrutiert |
| Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer | Phase I / Phase II | rekrutiert |
| Study of INCA036978 in Participants With Myeloproliferative Neoplasms | Phase I | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Wh | Phase III | rekrutiert |
| Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Diseas | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or | Phase II | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term | Phase III | rekrutiert |
| Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Co | Phase I / Phase II | rekrutiert |
| Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hyper | Phase III | rekrutiert |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Im | Phase III | rekrutiert |
| THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for t | ohne Phasenangabe | rekrutiert |
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemi | Phase I / Phase II | rekrutiert |
| Terumo Aortic Global Endovascular Registry | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Phase III | rekrutiert |
| The DefiPace Study | — | rekrutiert |
| The European NAFLD Registry | — | rekrutiert |
| The Freiburg Registry on SpontanEous IntercrAnial Hypotension (SIH) & Post-duraL Puncture Headac | — | rekrutiert |
| The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associate | ohne Phasenangabe | rekrutiert |
| The Pancreatic Enzymes After Gastrectomy Trial | Phase III | rekrutiert |
| The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry | — | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PU | ohne Phasenangabe | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Monitoring for NTM Infections With a Symptom Diary | — | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. | Phase II | rekrutiert |
| VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease | Phase IV | rekrutiert |
| Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Rela | Phase I / Phase II | rekrutiert |
| Vercise™ DBS Dystonia Prospective Study | — | rekrutiert |
| Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small Bowel | — | rekrutiert |